Distal Stent Graft-Induced New Entry After TEVAR or FET: Insights Into a New Disease From EuREC.


Journal

The Annals of thoracic surgery
ISSN: 1552-6259
Titre abrégé: Ann Thorac Surg
Pays: Netherlands
ID NLM: 15030100R

Informations de publication

Date de publication:
11 2020
Historique:
received: 27 07 2019
revised: 10 01 2020
accepted: 04 02 2020
pubmed: 14 4 2020
medline: 15 12 2020
entrez: 14 4 2020
Statut: ppublish

Résumé

The study sought to learn about incidence and reasons for distal stent graft-induced new entry (dSINE) after thoracic endovascular aortic repair (TEVAR) or after frozen elephant trunk (FET) implantation, and develop prevention algorithms. In an analysis of an international multicenter registry (EuREC [European Registry of Endovascular Aortic Repair Complications] registry), we found 69 dSINE patients of 1430 (4.8%) TEVAR patients with type B aortic dissection and 6 dSINE patients of 100 (6%) patients after the FET procedure for aortic dissection with secondary morphological comparison. The underlying aortic pathology was acute type B aortic dissection in 33 (44%) patients, subacute or chronic type B aortic dissection in 34 (45%) patients, acute type A aortic dissection in 3 patients and remaining dissection after type A repair in 3 (8%) patients, and acute type B intramural hematoma in 2 (3%) patients. dSINE occurred in 4.4% of patients in the acute setting and in 4.9% of patients in the subacute or chronic setting after TEVAR. After the FET procedure, dSINE occurred in 5.3% of patients in the acute setting and in 6.5% of patients in the chronic setting. The interval between TEVAR or FET and the diagnosis of dSINE was 489 ± 681 days. Follow-up after dSINE was 1340 ± 1151 days, and 4 (5%) patients developed recurrence of dSINE. Morphological analysis between patients after TEVAR with and without dSINE showed a smaller true lumen diameter, a more accentuated oval true lumen morphology, and a higher degree of stent graft oversizing in patients who developed dSINE. dSINE after TEVAR or FET is not rare and occurs with similar incidence after acute and chronic aortic dissection (early and late). Avoiding oversizing in the acute and chronic settings as well as carefully selecting patients for TEVAR in postdissection aneurysmal formation will aid in reducing the incidence of dSINE to a minimum.

Sections du résumé

BACKGROUND
The study sought to learn about incidence and reasons for distal stent graft-induced new entry (dSINE) after thoracic endovascular aortic repair (TEVAR) or after frozen elephant trunk (FET) implantation, and develop prevention algorithms.
METHODS
In an analysis of an international multicenter registry (EuREC [European Registry of Endovascular Aortic Repair Complications] registry), we found 69 dSINE patients of 1430 (4.8%) TEVAR patients with type B aortic dissection and 6 dSINE patients of 100 (6%) patients after the FET procedure for aortic dissection with secondary morphological comparison.
RESULTS
The underlying aortic pathology was acute type B aortic dissection in 33 (44%) patients, subacute or chronic type B aortic dissection in 34 (45%) patients, acute type A aortic dissection in 3 patients and remaining dissection after type A repair in 3 (8%) patients, and acute type B intramural hematoma in 2 (3%) patients. dSINE occurred in 4.4% of patients in the acute setting and in 4.9% of patients in the subacute or chronic setting after TEVAR. After the FET procedure, dSINE occurred in 5.3% of patients in the acute setting and in 6.5% of patients in the chronic setting. The interval between TEVAR or FET and the diagnosis of dSINE was 489 ± 681 days. Follow-up after dSINE was 1340 ± 1151 days, and 4 (5%) patients developed recurrence of dSINE. Morphological analysis between patients after TEVAR with and without dSINE showed a smaller true lumen diameter, a more accentuated oval true lumen morphology, and a higher degree of stent graft oversizing in patients who developed dSINE.
CONCLUSIONS
dSINE after TEVAR or FET is not rare and occurs with similar incidence after acute and chronic aortic dissection (early and late). Avoiding oversizing in the acute and chronic settings as well as carefully selecting patients for TEVAR in postdissection aneurysmal formation will aid in reducing the incidence of dSINE to a minimum.

Identifiants

pubmed: 32283085
pii: S0003-4975(20)30529-4
doi: 10.1016/j.athoracsur.2020.02.079
pii:
doi:

Types de publication

Comparative Study Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1494-1500

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Auteurs

Martin Czerny (M)

Department of Cardiovascular Surgery, University Heart Centre Freiburg, Bad Krozingen, Germany. Electronic address: martin.czerny@universitaets-herzzentrum.de.

Holger Eggebrecht (H)

Cardioangiological Center Bethanien, Frankfurt, Germany.

Herve Rousseau (H)

Department of Radiology, Centre Hospitalier Universitaire de Rangueil, Toulouse, France.

Paul Revel Mouroz (PR)

Department of Radiology, Centre Hospitalier Universitaire de Rangueil, Toulouse, France.

Rolf-Alexander Janosi (RA)

Department of Cardiology and Vascular Medicine, West German Heart and Vascular Center Essen, University of Duisburg-Essen, Essen, Germany.

Mario Lescan (M)

Department of Cardiothoracic and Vascular Surgery, University of Tübingen, Tübingen, Germany.

Christian Schlensak (C)

Department of Cardiothoracic and Vascular Surgery, University of Tübingen, Tübingen, Germany.

Dittmar Böckler (D)

Department of Vascular Surgery, Ruprecht-Karls University of Heidelberg, Heidelberg, Germany.

Marius Ante (M)

Department of Vascular Surgery, Ruprecht-Karls University of Heidelberg, Heidelberg, Germany.

Emma Vdr Weijde (EV)

Department of Cardiothoracic Surgery, St. Antonius Hospital, Nieuwegein, Germany.

Robin Heijmen (R)

Department of Cardiothoracic Surgery, St. Antonius Hospital, Nieuwegein, Germany.

Hans Henning Eckstein (HH)

Munich Aortic Centre, Department of Vascular and Endovascular Surgery, Klinikum rechts der Isar, Technical University of Munich, Munich Germany.

Benedikt Reutersberg (B)

Munich Aortic Centre, Department of Vascular and Endovascular Surgery, Klinikum rechts der Isar, Technical University of Munich, Munich Germany.

Santi Trimarchi (S)

Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico Milan, Milan, Italy.

Jürg Schmidli (J)

Department of Cardiovascular Surgery, Inselspital, University of Bern, Bern, Switzerland.

Thomas Wyss (T)

Department of Cardiovascular Surgery, Inselspital, University of Bern, Bern, Switzerland.

Romina Frey (R)

Department of Cardiovascular Surgery, Inselspital, University of Bern, Bern, Switzerland.

Vladimir Makaloski (V)

Department of Cardiovascular Surgery, Inselspital, University of Bern, Bern, Switzerland.

Jan Brunkwall (J)

Department of Vascular and Endovascular Surgery, University Hospital of Cologne, Cologne, Germany.

Spyridon Mylonas (S)

Department of Vascular and Endovascular Surgery, University Hospital of Cologne, Cologne, Germany.

Zoltan Szeberin (Z)

Department of Vascular Surgery, Semmelweis University, Budapest, Hungary.

Josef Klocker (J)

Department of Vascular Surgery, Medical University of Innsbruck, Innsbruck, Austria.

Roman Gottardi (R)

Department of Cardiovascular and Endovascular Surgery, Paracelsus Medical University of Salzburg, Salzburg, Austria.

Ingrid Schusterova (I)

East Slovakian Heart Center, Košice, Slovakia.

Julia Morlock (J)

Department of Cardiovascular Surgery, University Heart Centre Freiburg, Bad Krozingen, Germany.

Tim Berger (T)

Department of Cardiovascular Surgery, University Heart Centre Freiburg, Bad Krozingen, Germany.

Friedhelm Beyersdorf (F)

Department of Cardiovascular Surgery, University Heart Centre Freiburg, Bad Krozingen, Germany.

Bartosz Rylski (B)

Department of Cardiovascular Surgery, University Heart Centre Freiburg, Bad Krozingen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH